Why Pre-filled Syringes Are Becoming Central to Biologics Strategy
20 May 2026.Pre-filled syringes shift from convenience to strategic biologics delivery platform
Pre-filled syringes shift from convenience to strategic biologics delivery platform
The global Pre-Filled Syringes market is projected to grow at a CAGR of 9.2% by 2036
Defence procurement reform is reshaping readiness, investment and industrial competition
The global mRNA Vaccines market is projected to grow at a CAGR of 13.6% by 2036
Pharma distribution becomes strategic as speciality medicines reshape access and infrastructure
IoMT is reshaping healthcare through AI, wearables and connected care.
The global military identification friend or foe market is projected to grow at a CAGR of 9.7% by 2036
Defence demand rises, but delivery capacity now defines competitive advantage
CDMOs become strategic partners as biologics complexity reshapes pharmaceutical manufacturing
Defence readiness now depends on resilient supply chains and scalable delivery
Pharmaceutical packaging is becoming strategic, smarter, sustainable and growth-critical
The global Pharmaceutical Contract Manufacturing market is projected to grow at a CAGR of 7.9% by 2036
Defence demand rising, but execution and production capacity constrain delivery
The global Pharmaceutical Packaging market is projected to grow at a CAGR of 8.8% by 2036
The global mRNA Cancer Vaccine market is projected to grow at a CAGR of 27.1% by 2036
UDT 2026 highlights shift to undersea capability delivery and integration
Undersea defence shifts from concept to deployable, integrated capability
UDT 2026 day two: speed, autonomy and AUKUS shape defence
UDT 2026 update: maritime conflict reshapes undersea defence priorities
UDT 2026 day one highlights: subsea threats reshape defence priorities